ClinicalTrials.gg
RecruitingNCT07540117Updated Apr 23, 2026

Social Prescribing Intervention for Health Promotion in Community-Dwelling Older Adults

An interventional study of Mindfulness Meditation and Walking-Pole Exercise in Aging, Health Promotion and Mental Health, sponsored by National Health Research Institutes, Taiwan. Recruiting at 1 site in Taiwan. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-23.

Primary conditionPsychological Well-Being(the registry's first term)UnverifiedIs this wrong?Psychological Well-Being is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by National Health Research Institutes, Taiwan · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,500
Allocation
Not applicable
Ages
55 Years and older
Sex
All
01

Study summary

This study evaluates the effects of a social prescribing intervention on health promotion outcomes in community-dwelling older adults. The intervention consists of a 4-week mindfulness meditation program followed by a 12-week walking-pole exercise program. The purpose of the study is to determine whether this combined intervention improves physical function, psychological well-being, and sleep quality.

Eligible participants aged 55 years and older will be enrolled from community settings and will receive the same 16-week intervention. Assessments will be conducted at baseline, after the mindfulness phase, after completion of the full intervention, and 3 months after the intervention ends. Study outcomes include physical function, mood, well-being, sleep quality, and indicators of continued participation and lifestyle change.

The investigators hypothesize that the combined social prescribing intervention will lead to improvements in physical and psychological health among community-dwelling older adults and support healthy aging.

Read the detailed description

This study evaluates the effects of a social prescribing intervention on health promotion in community-dwelling older adults. The intervention combines 2 structured components delivered sequentially: a 4-week mindfulness meditation program followed by a 12-week walking-pole exercise program. The study is based on the concept that a combined mind-body and community-based intervention may improve both physical and psychological health and support healthy aging.

The study uses a prospective, single-group repeated-measures design. All enrolled participants receive the same 16-week intervention in community settings. The first phase consists of weekly group-based mindfulness meditation sessions designed to promote breathing awareness, relaxation, body awareness, emotional regulation, and positive psychological well-being. Participants are also encouraged to practice at home with guided audio support. The second phase consists of weekly group-based walking-pole exercise sessions focused on safe physical activity, strength, balance, mobility, and broader health promotion topics relevant to older adults.

The sequential design is intended to first establish psychological readiness and self-regulation and then build on this foundation through structured exercise. The investigators expect that the mindfulness phase may improve relaxation, emotional well-being, sleep, and self-regulation, while the walking-pole phase may improve physical function, lower-extremity strength, balance, and mobility. The study also examines whether participation in this combined program supports continued engagement in health-promoting behaviors.

Assessments are conducted at baseline, after completion of the mindfulness phase, after completion of the full intervention, and 3 months after the intervention ends. This design allows evaluation of short-term effects after the mindfulness phase, overall effects after the full intervention, and maintenance of effects at follow-up.

This study is intended to generate evidence for a feasible community-based social prescribing model for older adults. The findings may help support future development and implementation of integrated community programs that promote physical function, psychological well-being, and healthy aging.

02

Conditions studied

  • Aging
  • Health Promotion
  • Mental Health

Browse trials for

Keywords

  • Social Prescribing
  • Mindfulness Meditation
  • Walking Pole Exercise
  • Older Adults
  • Community-Dwelling Older Adults
  • Healthy Aging
  • Health Promotion
  • Psychological Well-Being
  • Sleep Quality
  • Physical Function
03

In context

Psychological Well-Being Unverified

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

This study's planned enrollment of 1,500 is above the median of 110 across 1,808 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

National Health Research Institutes, Taiwan is the lead sponsor of 129 studies on the registry; 31 are open to participants now.

Compared within Psychological Well-Being, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 55 years and older
  • Community-dwelling older adults
  • Able to walk independently or with assistive devices
  • Normal cognitive function or mild cognitive impairment, with ability to understand and follow study procedures
  • Willing to sign
  • Willing to participate in the intervention and complete study assessments

Exclusion criteria

Exclusion Criteria:

  • Major surgery or hospitalization within the previous 3 months
  • Severe cardiovascular disease or other medical condition making exercise inappropriate, based on physician assessment
  • Moderate to severe dementia or other severe psychiatric disorder
  • Inability to comply with the 4-week mindfulness meditation program or the 12-week walking-pole exercise program
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1,500 participants (estimated)

Study arms

  • Experimental
    Mindfulness Meditation Plus Walking-Pole Exercise

    Behavioral: Mindfulness Meditation and Walking-Pole Exercise

Interventions

  • BehavioralMindfulness Meditation and Walking-Pole Exercise

    1. Mindfulness Meditation A 4-week group-based mindfulness meditation program delivered once weekly for approximately 60 minutes per session. The program includes breathing awareness, body awareness, relaxation training, emotion regulation, and positive psychological practices. Sessions are conducted in person by trained instructors and are supported by guided home practice using audio content. The purpose of this phase is to promote psychological well-being, relaxation, sleep improvement, and self-regulation before the exercise phase begins. 2. Walking-Pole Exercise A 12-week group-based walking-pole exercise program delivered once weekly for approximately 60 to 90 minutes per session. The program includes warm-up, structured walking-pole exercise, cool-down, and brief calming or meditative practice. It focuses on muscle strengthening, balance training, mobility, functional movement, and health promotion activities relevant to older adults. Sessions are led by qualified instructors,

06

What researchers measure

Primary outcomes

  1. Five Times Sit-to-Stand Test

    Time in seconds required to complete the Five Times Sit-to-Stand Test, used to assess lower-extremity muscle strength and functional mobility. Lower values indicate better performance.

    Time frame: Baseline, at Week 5, and at Week 17

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study involves community-dwelling older adults and includes sensitive personal and health-related information. To protect participant privacy and comply with institutional review board and data protection requirements, no individual-level de-identified dataset is currently planned for public sharing. Study findings will be reported in aggregate form only.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Apr 2029, 36 months after the start.

Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 36 months is above that.

Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2026
First posted
Apr 20, 2026
StartActual
Apr 14, 2026
Primary completionEst.
Apr 2029
CompletionEst.
Apr 2029
Last update
Apr 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07540117
Responsible party
Sponsor
First posted
Apr 20, 2026
Start date
Apr 14, 2026
Primary completion
Apr 2029 (estimated)
Completion
Apr 2029 (estimated)
Last update
Apr 23, 2026

Study contacts

Ren-Hua Chung, PhD
Contact
rchung@nhri.edu.tw
886-37206166 ext. 36105

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion